Vertex Pharmaceuticals Inc. buy Barclays PLC
Start price
11.12.23
/
50%
€327.60
Target price
11.12.24
€385.41
Performance (%)
35.84%
End price
12.12.24
€445.00
Summary
This prediction ended on 12.12.24 with a price of €445.00. With a performance of 35.84% the BUY prediction by Barclays_PLC was a big success. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 3.628% | 3.628% | -13.128% |
| iShares Core DAX® | 1.917% | 1.088% | 17.187% |
| iShares Nasdaq 100 | 0.911% | 1.674% | 7.930% |
| iShares Nikkei 225® | 0.833% | -1.712% | 12.100% |
| iShares S&P 500 | 0.242% | 1.258% | 3.167% |
Comments by Barclays_PLC for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Barclays PLC from $408.00 to $415.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Barclays_PLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€387.70
06.02.24
06.02.24
€439.24
06.02.25
06.02.25
19.98%
07.02.25
07.02.25
